Skip to main content

Global Breast Cancer Treatment Market is Expected to Reach USD 10,682.6 Mn by 2022: Credence Research

The latest market report published by Credence Research, Inc. “Global Breast Cancer Treatment Market- Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 - 2022,” the breast cancer treatment market was valued at USD 10,682.6 Mn in 2015, and is expected to reach USD 17,345.8 Mn by 2022, expanding at a CAGR of 7.6% from 2016 to 2022.
Browse the full report Breast Cancer Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at http://www.credenceresearch.com/report/breast-cancer-treatment-market
Market Insights:
Breast cancer is typically detected either during a screening examination, before symptoms have developed, or after a woman notices a lump. According to market experts, breast cancer is the second-largest cause of cancer deaths globally. The rising prevalence of breast cancer across the developed nations has boosted the involvement of non-governmental associations that are spreading awareness related to breast cancer diagnostics and treatment in public. Therapeutic treatment preferred to treat breast cancer involves synthetic to biological drugs. The awareness created around the world in last decade has assisted the market growth along with market introduction of premium priced therapies. Moreover, drugs for breast cancer have seen accelerated approvals, thereby providing impetus for breast cancer research and shifting the equilibrium toward research of new effective pathways for intervention of breast cancer. On the other hand, the geographical analysis of breast cancer treatment market projected North America and Europe as the dominant regions followed by Asia-Pacific.  The key factors driving the breast cancer market in the world include developed research and development facilities, upcoming drug launches, and mounting incidences and awareness of the breast cancer in developing countries. Thus, rising incidences of breast cancer and novel product approvals will lead to significant market growth during the forecast period, despite generic sales erosion resulting from patent expirations.
Pipeline Analysis:                 
The phase III drugs included in the pipeline analysis are Abemaciclib (Eli Lily & Company), Buparlisib (Novartis), NeuVax (Galena Biopharma), Niraparib (Tesaro), Lynparza (AstraZeneca), Veliparib (AbbVie), Neratinib (Puma Biotechnology), Ribociclib (Novartis) and others. According to market experts, these upcoming drugs assure to provide enhanced efficacy, shorter onset of action and fewer side effects as compared to the currently available breast cancer treatment. Thus, future commercialization of these molecules during the forecast period 2016 – 2022 is anticipated to have a reflective impact on the growth of the overall breast cancer treatment market.
Key Market Movements:
  • North America presently dominates the overall market and is also projected to experience the fastest growth throughout the forecast period
  • The recent market entry of novel drugs including Perjeta, a targeted therapy; Kadcyla, a human antibody-drug conjugate; and Halaven, a novel chemotherapeutic agent have boosted the overall growth of breast cancer treatment market
  • The companies have been able to develop efficient and commercially successful products by studying pathophysiology of breast cancer in detail, e.g. Herceptin, which is build on the existing scientific groundwork.
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology
Chapter 2 Executive Summary
2.1 Global Breast Cancer Treatment Market Portaiture
2.2 Global Breast Cancer Treatment Market Treament Market, by Drug Class, 2015 (USD Mn)
2.3 Relativity Analysis: Global Breast Cancer Treatment Market, by Geography, 2015 & 2022 (USD Mn)
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290

Comments

Post a Comment

Popular posts from this blog

Algae Products Market Key Growth Factors and Industry Analysis 2023: Credence Research

According to a new market report published by Credence Research “ Algae Products Market  - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2023,” the algae products market is expected to reach US$ 44.7 Bn by 2023, expanding at a CAGR of more than 5.0% from 2016 to 2023. Browse the full report at  http://www.credenceresearch.com/report/algae-products-market Market Insights: Algae are a diverse group of photosynthetic organisms which are not closely related and hence are known to be polyphyletic. They are plats which range from microalgae to macro algae. Algae are grown using water resources such as sea and waste water which are not suitable for growing agricultural crops. Microalgae grow using sunlight i.e. photosynthesis, by converting sunlight, CO2 and nutrients such as phosphorus and nitrogen into biomass. This growth is also known as autotrophic growth. Some algae can grow in the dark using sugar starch or by combining both the growth modes. Based on applica
Post a Comment
Read more

Articulated Arm Machine Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023

According to a new market report published by Credence Research, Inc., “ Articulated Arm Machine Market  (By End-use Application (Industrial Manufacturing, Automotive, Electronics and Electrical, Aerospace, Energy and Power, and Other End-use Applications), By Price (Low-end Articulated Arms, Mid-range Articulated Arms, and High-end Articulated Arms)) - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 - 2023”, the global articulated arm machine market is expected to witness steady growth in demand, expanding at a CAGR of 8.2% during the forecast period 2016 to 2023. Browse the full Articulated Arm Machine (By End-use Application (Industrial Manufacturing, Automotive, Electronics and Electrical, Aerospace, Energy and Power, and Other End-use Applications), By Price (Low-end Articulated Arms, Mid-range Articulated Arms, and High-end Articulated Arms)) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023 report at  http://www.crede
Post a Comment
Read more

Base Oil Market Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 – 2023: Credence Research

Credence Research has recently issued a new market assessment report titled “Base Oil – Growth, Future Prospects and Competitive Analysis, 2016 – 2023”. The global Base Oil Market study provides a comprehensive view of the ongoing and future phases of the Base Oil industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at  http://www.credenceresearch.com/report/base-oil-market Based on geographic/regional distribution the global Base Oil Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Base Oil Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa markets. Among these, the North America, Europe and Asia-Pacific Ba
Post a Comment
Read more